CoChat

Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulationThis review is one of a selection of papers published in a Special Issue on Oxidative Stress in Health and Disease.

Kakhlon, Or, Breuer, William, Munnich, Arnold, Cabantchik, Z. Ioav · 2010 · Canadian Journal of Physiology and Pharmacology
Cited by 48

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Defective iron utilization leading to either systemic or regional misdistribution of the metal has been identified as a critical feature of several different disorders. Iron concentrations can rise to toxic levels in mitochondria of excitable cells, often leaving the cytosol iron-depleted, in some forms of neurodegeneration with brain accumulation (NBIA) or following mutations in genes associated with mitochondrial functions, such as ABCB7 in X-linked sideroblastic anemia with ataxia (XLSA/A) or the genes encoding frataxin in Friedreich’s ataxia (FRDA). In anemia of chronic disease (ACD), iron is withheld by macrophages, while iron levels in extracellular fluids (e.g., plasma) are drastically reduced. One possible therapeutic approach to these diseases is iron chelation, which is known to effectively reduce multiorgan iron deposition in iron-overloaded patients. However, iron chelation is probably inappropriate for disorders associated with misdistribution of iron within selected tissues or cells. One chelator in clinical use for treating iron overload, deferiprone (DFP), has been identified as a reversed siderophore, that is, an agent with iron-relocating abilities in settings of regional iron accumulation. DFP was applied to a cell model of FRDA, a paradigm of a disorder etiologically associated with cellular iron misdistribution. The treatment reduced the mitochondrial levels of labile iron pools (LIP) that were increased by frataxin deficiency. DFP also conferred upon cells protection against oxidative damage and concomitantly mediated the restoration of various metabolic parameters, including aconitase activity. Administration of DFP to FRDA patients for 6 months resulted in selective and significant reduction in foci of brain iron accumulation (assessed by T2* MRI) and initial functional improvements, with only minor changes in net body iron stores. The prospects of drug-mediated iron relocation versus those of chelation are discussed in relation to other disorders involving iron misdistribution, such as ACD and XLSA/A.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1139/y09-128

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 65

  1. 10.1021/jm070800l · DOI · Paper page
  2. Bottomley S.S., 2006, Curr. Hematol. Rep., 5, 41
  3. 10.1182/blood.V97.3.792 · DOI · Paper page
  4. 10.1016/j.nurt.2008.05.001 · DOI · Paper page
  5. 10.1111/j.1365-2141.2008.07290.x · DOI
  6. 10.1182/blood-2002-10-3280 · DOI · Paper page
  7. 10.1016/S1474-4422(07)70220-X · DOI · Paper page
  8. 10.1111/j.1600-0609.2007.00840.x · DOI
  9. 10.1006/abio.1997.2126 · DOI · Paper page
  10. Evans R.W., 1992, Drugs Today (Barc), 28, 19
  11. 10.1002/mds.22002 · DOI · Paper page
  12. 10.1016/0300-483X(95)03301-U · DOI
  13. 10.1002/pbc.20656 · DOI · Paper page
  14. 10.1182/blood-2005-02-0460 · DOI · Paper page
  15. 10.1182/blood-2006-05-020867 · DOI · Paper page
  16. Gregory A., 2005, Folia Neuropathol., 43, 286
  17. Gutteridge J.M.C., 2000, Ann. N. Y. Acad. Sci., 899, 136, 10.1111/j.1749-6632.2000.tb06182.x · DOI · Paper page
  18. 10.1016/S0006-2952(99)00031-3 · DOI
  19. 10.1172/JCI115422 · DOI · Paper page
  20. 10.1016/j.spen.2006.08.007 · DOI
  21. 10.1111/j.1365-2141.2004.04946.x · DOI · Paper page
  22. 10.1196/annals.1345.015 · DOI
  23. 10.1021/bi990438f · DOI · Paper page
  24. 10.1046/j.1365-2141.1996.d01-1795.x · DOI · Paper page
  25. 10.1196/annals.1306.023 · DOI · Paper page
  26. 10.1182/blood-2008-06-161919 · DOI · Paper page
  27. Konijn A.M., 1999, Blood, 94, 2128, 10.1182/blood.V94.6.2128 · DOI · Paper page
  28. 10.1039/an9952000845 · DOI
  29. 10.1016/S0140-6736(87)90545-9 · DOI · Paper page
  30. 10.1093/hmg/ddn127 · DOI · Paper page
  31. 10.1146/annurev.biochem.76.052705.162653 · DOI · Paper page
  32. 10.1124/mol.108.046847 · DOI
  33. 10.1111/j.1440-1681.2008.05114.x · DOI
  34. 10.1136/gut.2003.030429 · DOI · Paper page
  35. 10.1016/0140-6736(91)92978-B · DOI · Paper page
  36. 10.1177/1352458507078916 · DOI · Paper page
  37. 10.1016/j.ajhg.2007.12.012 · DOI · Paper page
  38. 10.1007/s10534-006-9033-z · DOI · Paper page
  39. 10.1182/blood-2004-10-3856 · DOI · Paper page
  40. 10.1007/s00415-009-1002-3 · DOI · Paper page
  41. 10.1007/s00415-009-1003-2 · DOI · Paper page
  42. 10.1515/BC.2002.051 · DOI · Paper page
  43. 10.1002/ajh.21100 · DOI · Paper page
  44. 10.1007/s00415-009-1004-1 · DOI
  45. 10.1196/annals.1306.026 · DOI · Paper page
  46. Richardson D.R., 2001, Biochim. Biophys. Acta, 1536, 133, 10.1016/S0925-4439(01)00041-2 · DOI · Paper page
  47. 10.1016/j.tig.2008.05.008 · DOI · Paper page
  48. 10.1159/000065700 · DOI · Paper page
  49. 10.1073/pnas.88.15.6585 · DOI · Paper page
  50. Singh S., 1995, Biochem. Soc. Symp., 61, 127, 10.1042/bss0610127 · DOI · Paper page
  51. 10.1136/jnnp.2007.120568 · DOI
  52. Spivak J.L., 2002, Oncology (Williston Park), 16, 25
  53. 10.1016/S0140-6736(89)92011-4 · DOI
  54. 10.1136/ard.49.11.956-b · DOI
  55. Vreugdenhil G., 1991, Clin. Exp. Rheumatol., 9, 35
  56. 10.1016/0006-2952(93)90222-I · DOI
  57. 10.1002/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H · doi:10.1002/1531-8249(199907)46:1<123::aid-ana19>3.0.co;2-h
  58. 10.1016/0006-2952(94)00521-M · DOI
  59. 10.1016/j.bbagen.2008.08.006 · DOI · Paper page
  60. 10.1073/pnas.0804261105 · DOI · Paper page
  61. 10.1016/j.spen.2006.08.005 · DOI
  62. 10.1007/BF03033574 · DOI
  63. Zanella I., 2008, Biochim. Biophys. Acta, 1782, 90, 10.1016/j.bbadis.2007.11.006 · DOI
  64. Zanninelli G., 1997, Mol. Pharmacol., 51, 842, 10.1124/mol.51.5.842 · DOI
  65. 10.1038/ng572 · DOI · Paper page

Cited by

Metadata

Authors
Kakhlon, O., Breuer, W., Munnich, A., & Cabantchik, Z. I.
Venue
Canadian Journal of Physiology and Pharmacology
Published
2010-03
Volume
88
Issue
3
Pages
187-196
ISSN
  • 0008-4212 (ISSN-L)
  • 1205-7541
OpenAlex
W1513950293
Cited by
48
References
25
Type
journal article
Language
en
Open access
closed
Licence
www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.